BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2121568)

  • 1. Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM.
    Mitrakou A; Kelley D; Veneman T; Jenssen T; Pangburn T; Reilly J; Gerich J
    Diabetes; 1990 Nov; 39(11):1381-90. PubMed ID: 2121568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.
    Consoli A; Nurjhan N; Reilly JJ; Bier DM; Gerich JE
    J Clin Invest; 1990 Dec; 86(6):2038-45. PubMed ID: 2254458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues.
    Firth RG; Bell PM; Marsh HM; Hansen I; Rizza RA
    J Clin Invest; 1986 May; 77(5):1525-32. PubMed ID: 3517067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM.
    Consoli A; Nurjhan N; Capani F; Gerich J
    Diabetes; 1989 May; 38(5):550-7. PubMed ID: 2653926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus.
    Kelley D; Mokan M; Veneman T
    Metabolism; 1994 Dec; 43(12):1549-57. PubMed ID: 7990710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
    McMahon M; Marsh HM; Rizza RA
    Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased activation of skeletal muscle glycogen synthase by mixed-meal ingestion in NIDDM.
    Wright KS; Beck-Nielsen H; Kolterman OG; Mandarino LJ
    Diabetes; 1988 Apr; 37(4):436-40. PubMed ID: 2837418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.
    Kelley D; Mitrakou A; Marsh H; Schwenk F; Benn J; Sonnenberg G; Arcangeli M; Aoki T; Sorensen J; Berger M
    J Clin Invest; 1988 May; 81(5):1563-71. PubMed ID: 3130396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus.
    Ludvik B; Nolan JJ; Roberts A; Baloga J; Joyce M; Bell JM; Olefsky JM
    J Clin Invest; 1997 Nov; 100(9):2354-61. PubMed ID: 9410915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE; Mokan M; Mandarino LJ
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes.
    Meyer C; Woerle HJ; Dostou JM; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1049-56. PubMed ID: 15304374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to postprandial hyperglycemia and effect on initial splanchnic glucose clearance of hepatic glucose cycling in glucose-intolerant or NIDDM patients.
    Butler PC; Rizza RA
    Diabetes; 1991 Jan; 40(1):73-81. PubMed ID: 2015976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals.
    Avogaro A; Toffolo G; Miola M; Valerio A; Tiengo A; Cobelli C; Del Prato S
    J Clin Invest; 1996 Jul; 98(1):108-15. PubMed ID: 8690781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A; Alford F; Henriksen FL; Christopher M; Beck-Nielsen H
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM.
    Gerich JE; Mitrakou A; Kelley D; Mandarino L; Nurjhan N; Reilly J; Jenssen T; Veneman T; Consoli A
    Diabetes; 1990 Feb; 39(2):211-6. PubMed ID: 2227129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.
    Alzaid AA; Dinneen SF; Turk DJ; Caumo A; Cobelli C; Rizza RA
    J Clin Invest; 1994 Dec; 94(6):2341-8. PubMed ID: 7989590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma alanine and lactate concentrations following glucose ingestion in normal and NIDDM subjects.
    Donatelli M; Russo V; Bucalo ML; Scarpinato A; Veronelli A; Craveri A
    Diabetes Res; 1992; 20(4):121-6. PubMed ID: 1345005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance.
    Mitrakou A; Kelley D; Mokan M; Veneman T; Pangburn T; Reilly J; Gerich J
    N Engl J Med; 1992 Jan; 326(1):22-9. PubMed ID: 1727062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes.
    Woerle HJ; Szoke E; Meyer C; Dostou JM; Wittlin SD; Gosmanov NR; Welle SL; Gerich JE
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E67-E77. PubMed ID: 16105859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.